Immunovant Inc - ESG Rating & Company Profile powered by AI
Full Sustainability analysis of Immunovant Inc are accessed by signing in. Other companies in the scoring peer group for Immunovant Inc are shownin the table. This ESG score covers seventeen United Nations SDGs including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Life on Land'.
Immunovant Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 8.0, social score of 1.6 and governance score of 8.0.
5.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 669 | Viridian Therapeutics Inc | 6.0 | High |
| 669 | Vistin Pharma ASA | 6.0 | High |
| 716 | Immunovant Inc | 5.9 | High |
| 716 | Akeso Inc | 5.9 | High |
| 716 | Alfresa Holdings Corp | 5.9 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Immunovant Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Immunovant Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Immunovant Inc report the average age of the workforce?
Sign up for free to unlockDoes Immunovant Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Immunovant Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Immunovant Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Immunovant Inc offer flexible work?
Sign up for free to unlockDoes Immunovant Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Immunovant Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Immunovant Inc conduct supply chain audits?
Sign up for free to unlockDoes Immunovant Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Immunovant Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Immunovant Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Immunovant Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Immunovant Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Immunovant Inc disclose water use targets?
Sign up for free to unlockDoes Immunovant Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Immunovant Inc have a product recall in the last two years?
Sign up for free to unlockDoes Immunovant Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Immunovant Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Immunovant Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Immunovant Inc disclose parental leave metrics?
Sign up for free to unlockDoes Immunovant Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Immunovant Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Immunovant Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Immunovant Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Immunovant Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Immunovant Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Immunovant Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Immunovant Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Immunovant Inc disclose its waste policy?
Sign up for free to unlockDoes Immunovant Inc report according to TCFD requirements?
Sign up for free to unlockDoes Immunovant Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Immunovant Inc disclose energy use targets?
Sign up for free to unlockDoes Immunovant Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Immunovant Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Immunovant Inc
These potential risks are based on the size, segment and geographies of the company.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.